GOVERNING BODY REPORT

Size: px
Start display at page:

Download "GOVERNING BODY REPORT"

Transcription

1 GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical priority areas. Nationally, the cost of coronary heart disease is 9 billion per year through health care costs, informal care and production losses associated with mortality and morbidity. Nationally in 2008, 88,000 deaths were caused by coronary heart disease. In West Cheshire, death rates from heart disease and stroke in the under 75s are falling. They are lower than the national average but similar to our Office of National Statistics Cluster group. However, it is deaths from heart disease and stroke and, in particular, coronary heart disease that are driving the widening health inequalities between our most deprived two quintiles and the rest of the population. N-terminal pro b-type natriuretic peptide (NTproBNP) testing was commissioned for use in primary care from the 1 st April Specialist Assessment two week echocardiogram referrals launched on the 11 th July Work is progressing on the implementation of the remaining service developments described in the Commissioning Plan and on outline plans for REPORT PREPARED BY: Dr Lesley Appleton, Clinical Lead for Heart Disease Paul Lynch, Planning & Performance Manager Vicky Oxford, Locality Support Manager

2 NHS WEST CHESHIRE CLINICAL COMMISSIONING GROUP GOVERNING BODY HEART DISEASE UPDATE INTRODUCTION 1. NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of the six clinical priorities that it intends to focus on over the next five years in order to improve health outcomes for its population. 2. This paper sets out the national and local position regarding the impact and costs associated with heart disease. It also details the service developments which have been agreed, their status in terms of implementation and the next steps. NATIONAL POSITION 3. Heart and circulatory disease is the UK s most common cause of death In 2008, over 191,000 people died from heart and circulatory disease in the UK, of which 88,000 deaths were caused by coronary heart disease (this is one in five male deaths and one in eight female deaths). 5. In the UK in 2008 coronary heart disease caused more than 28,000 premature deaths. 6. There are approximately 124,000 heart attacks in the UK each year. 7. The most recent data available shows that in 2006, coronary heart disease in the UK cost the health care system in the region of 3.2 billion per year, of which 73% was in hospital care costs. 8. Coronary heart disease also incurs non-health care costs in the form of production losses associated with mortality and morbidity. In 2006, these were estimated to be in the region of 3.9 billion. 9. In 2006, the cost of informal care for people with coronary heart disease in the UK was around 1.8 billion. LOCAL POSITION 10. Through the Joint Strategic Needs Assessment, heart disease has been identified as a key health issue for our population. 1 1 All national statistics are drawn from: British Heart Foundation Health Promotion Research Group. (2010). Coronary Heart Disease Statistics. Oxford: Department of Public Health University of Oxford. 1

3 11. Analysis indicates that: In Cheshire West and Chester there are around 3,000 deaths a year, of which 75% are caused by either circulatory diseases, cancer or respiratory conditions; Death rates from heart disease and stroke in the under 75s are falling. They are lower than the national average but similar to our Office of National Statistics Cluster group. However, it is deaths from heart disease and stroke and in particular coronary heart disease that are driving the widening health inequalities between our most deprived two quintiles and the rest of the population; Coronary heart disease contributes 22% to the male health inequality gap and 11% of the female health inequality gap; Although death rates have been improving in the most deprived areas the rate of improvement has not been as fast as in the rest of the population particularly amongst men; There is an ageing population in West Cheshire which means that people will live long enough to develop conditions associated with ageing including coronary heart disease; In West Cheshire, 32.6% (64,100) of adults have raised blood pressure (either being treated for hypertension or have a one-off recording of >140/90); Currently there are 33,750 patients on our GP practice hypertension registers, which equates to 16% of our adult population. There is therefore possibly a further 17% in our population with raised blood pressure; Raised blood pressure is a significant risk factor for coronary heart disease and stroke; In West Cheshire, around 9,650 patients have been diagnosed with coronary heart disease and there are approximately 2,100 patients on the heart failure registers of our GP practices. COST TO THE LOCAL HEALTH ECONOMY 12. In the financial year , 9.3million was spent by the Primary Care Trust on coronary heart disease in West Cheshire. ENGAGEMENT 13. Local clinical engagement highlighted a number of key issues which build on requirements set out in the National Institute for Health and Clinical Excellence (NICE) Guidelines and Quality Standards. Issues raised by clinicians included: Lack of availability of N-terminal pro b-type natriuretic peptide (NTproBNP) testing in primary care; Lack of two week referral pathway and specialist assessment for echocardiograms; 2

4 Issues with waiting times for diagnostic echocardiograms, for example, patients waiting longer for an echocardiogram than the six week target; Lack of formal cardiac rehabilitation programme for heart failure patients. 14. Patient and public engagement has taken place with groups including the Local Involvement Network, a local carer s support group, the Chester Youth Parliament and the Older Peoples Network around the health priorities for the local population and heart disease was identified as an area of concern. 15. Further engagement is planned on the heart disease agenda in November 2012 where the Clinical Lead for Heart Disease will be meeting the Chester Heart Support Group to talk about the Clinical Commissioning Group s current plans and future intentions. STRATEGIC AIMS AND OUTCOMES 16. The local clinical engagement feedback has been included in West Cheshire Clinical Commissioning Group s strategic plan for which sets out what we want to achieve during that period: Review the Heart Failure diagnostics in line with national guidance; Review access and increase uptake to cardiac rehabilitation; Increase the uptake of Smoking Cessation Programmes. Patients who are diagnosed with coronary heart disease who stop smoking can significantly improve their health outcomes; Improve prescribing. We will ensure the increased prescription of non-branded statins where appropriate, ensuring that those patients, who would benefit from taking a statin, do so. IMPLEMENTATION AND PROGRESS 17. The following section illustrates our progress against the aims set out in the Commissioning Plan Heart Failure Pathway 18. Following the clinical feedback and research into service gaps the Commissioning Delivery Committee approved a business case to develop the heart failure pathway in West Cheshire in line with NICE Guidance and Quality Standards. The service developments agreed were: The implementation of the NICE Heart Failure Guidance which consists of the commissioning of NTproBNP testing and its use for monitoring appropriate patients, the commissioning of echocardiogram specialist assessment and a redesign of cardiac rehabilitation to incorporate a programme for patients with heart failure; The pathway will be implemented using a phased approach. 3

5 19. A project group has been established and the following progress has been made: Hypertension N-terminal pro b-type natriuretic peptide testing was commissioned for use in primary care from the 1 st April 2012; Two week specialist assessment for echocardiogram was launched on the 11 th July 2012; A service specification has been developed for an expanded cardiac rehabilitation service to incorporate a programme for patients with heart failure. This is currently being negotiated with the provider and it is anticipated that the heart failure programme element will commence in January In response to local need and the revised NICE Guidelines on Hypertension, an application for funding from the Innovation Fund was developed and this was discussed at the Ellesmere Port and Neston GP Network and a recommendation for approval was made to the Commissioning Delivery Committee. The Commissioning Delivery Committee approved the bid and the following development was agreed: A 24 hour blood pressure monitor and five years servicing for the monitor will be purchased for each of the 37 member practices using funding from the Innovation Fund. 21. The following progress has been made: The 24 hour blood pressure monitors have been ordered and distributed to member practices in September; A training session on how to utilise the units will be arranged for each locality. Cardiology One Stop Shop 22. The following progress has been made against our intention to investigate the feasibility of a cardiology one stop shop: An Initial Viability Assessment for a cardiology one stop shop was produced and approval was given by the Project Delivery Group to develop an outline business case; An outline business case has been developed with a proposed model of care; The model of care would include consultant input; echocardiogram; 24 hour blood pressure monitoring; 7 day event recording; cardio memo event recording; nurse led clinics; and out-patient clinics; The proposed model of care was presented to the three GP Locality Networks in September for further clinical comment; 4

6 An outline business case will be submitted and discussed by the Commissioning Delivery Committee in October where a decision on the next steps will be made. Health Check Local Enhanced Service 23. A Health Check Local Enhanced Service has been developed by Public Health. The scheme will target high risk populations and seek to address some of the health inequalities and lifestyle related conditions that impact on the prevalence and incidence of heart disease and stroke in accordance with the NHS Constitution. To date, 33 practices of the 37 member practices have committed to deliver health checks to the targeted cohorts of patients. The 33 practices started the Health Check Local Enhanced Service in June and the target is to deliver health checks to 20% of the target population each year, over a five year rolling programme. 24. GP practices that are not currently committed to deliver the service will have the opportunity to commit if they wish to do so within the next six months. Stroke Care Pathway 25. We are moving forward with our plans to improve the delivery of care to maximise patient independence and reduce the burden on health and social care services. The proposed next steps, some of which will be subject to funding availability include: Maximising the identification and effective management of patients with Atrial Fibrillation (AF) to enhance Stroke prevention; Supporting proposals to develop an integrated and combined Acute and Rehabilitation Stroke Unit to include integrated therapy services to enable improved patient management and a reduced average length of stay; The unbundling of the mandatory Payment by Results (PbR) tariff for Stroke to separate payment for various phases of care (e.g. A&E, hyper-acute, acute/acute rehabilitation) and support for a proposal to conduct a pilot to deliver a costed pathway for stroke patients; Investigating improving access to psychological support for stroke and Transient Ischaemic Attack (TIA) patients and their carers; Investigating the commissioning of a six month post stroke review service Developing the capacity of community based services to support and manage patients with Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes and Nasogastric feeds appropriately within their usual place of residence; A community based Early Supported Discharge / Supported Discharge service has already been commissioned. 5

7 MEASURABLE BENEFITS 26. The following benefits have been identified: Commissioning of NTproBNP testing will lead to a reduction of up to 40% in the number of echocardiograms for a diagnosis of heart failure. This, in turn, will alleviate some of the pressure on waiting times for diagnostic tests. This will be monitored through the contracting dataset with our main provider; Patients identified as being at high risk of heart failure can be referred to the specialist assessment within two weeks facilitating earlier identification and management of heart failure and help reduce hospital admissions (23% reduced risk per patent of being admitted to hospital within the first six months). This will contribute to the NHS Outcomes Framework (2011), Domain 1: Preventing people from dying prematurely Reducing premature mortality from the major causes of death; Implementation of these services will improve patient experience through a redesigned pathway, provide care closer to home where appropriate and facilitate a reduction in waiting times for diagnostic echocardiograms. Patient reported outcomes will also improve through quicker exclusion of heart failure diagnosis providing reassurance to patients. Patient experience and patient reported outcomes will be monitored through key performance indicators, a contractual requirement for all service providers; A potential reduction in cardiology out-patient follow up appointments through the development of a cardiology one stop shop; Increased GP confidence in excluding heart failure; The provision of 24 hour ambulatory blood pressure monitors in primary care will alleviate the need to send patients to secondary care for a 24 hour ambulatory blood pressure test, and promote care closer to home. FINANCIAL IMPACT 27. Initial estimates from the NICE costing model for the heart failure pathway indicate potential savings of 98,946 per annum. This is based on the commissioning of NTproBNP testing and its use in monitoring appropriate patients, specialist assessment and the expansion of cardiac rehabilitation to include a heart failure programme. The estimated savings are predicated on a reduction in the number of echocardiograms for a diagnosis of heart failure and a reduction in hospital admissions for heart failure. 28. The NICE guidelines for hypertension recommend 24 hour ambulatory blood pressure monitoring for patients presenting with suspected hypertension, which will result in an increased number of patients requiring the diagnostic test currently available in secondary care and increased costs for the test, along with a potential increase in waiting 6

8 times. Initial modelling based on hypertension incidence indicated that costs could increase by approximately 85,000 per annum. The provision of 24 hour ambulatory blood pressure monitors in primary care will alleviate this increase in costs and help mitigate the impact on diagnostic waiting times. 29. The financial modelling completed for the cardiology one stop shop is predicated on a reduction in out-patient follow-up appointments as patients will receive the diagnostic test, consultant opinion and results in the same appointment rather than re-attending for test results. Initial modelling estimates that savings in the region of 59,000 per annum may be achieved. 30. These estimated savings would contribute towards the Clinical Commissioning Group s Quality, Innovation, Productivity and Prevention (QIPP) programme. QUALITY IMPROVEMENTS Commissioning for Quality and Innovation 31. The 2012/13 Commissioning for Quality and Innovation (CQUIN) scheme agreed with Cheshire and Wirral Partnership NHS Foundation Trust contains a goal to develop advanced care planning and an end of life care pathway for patients with heart failure. Quarterly milestones have been set for this goal and performance against these is reported through the regular quality and risk meetings as part of the contract monitoring process. Quarter one milestones were reported in August and all requirements were met. Quarter two progress will be reported in October. Quality Incentive Scheme 32. In , member practices have signed up to our Quality Incentive Scheme which supports the continuous quality improvement of its member GP Practices. As part of the Quality Incentive Scheme, member GP practices undertake three quality indicators aimed at improving the health and wellbeing of the clinical commissioning group s population. Three of the seven indicators in the Scheme focus on heart disease and stroke: Improving cholesterol control in patients with coronary heart disease (CHD) 19 GP practices are undertaking this indicator; Review of heart failure care against NICE Clinical Guideline 108, to include beta blocker prescribing 17 GP practices are undertaking this indicator; Improving the identification of atrial fibrillation through opportunistic pulse checking in patients aged 65 years and over (for GP practices whose actual prevalence rate is below their predicted prevalence rate) 15 GP practices are undertaking this indicator. 7

9 COLLABORATIVE WORKING WITH LOCAL AUTHORITY PARTNERS 33. As part of the work on stroke, a community based Early Supported Discharge / Supported Discharge service has been commissioned which integrates health and social care to provide a seamless pathway. 34. We are also working as an active partner in the Altogether Better Cheshire Programme in collaboration with partner organisations including the Cheshire West and Chester Council. A full business case is currently in development with the aim of creating integrated health and social care teams wrapped around GP practice populations. These teams will focus on managing people, predominantly older adults and those with long term conditions such as heart failure, in the community, avoiding hospital admissions where appropriate and supporting patients who have been discharged from secondary care in the community. A workshop focused on the development of integrated teams is being held in each of the three GP Locality Networks in September. The programme is also in the process of recruiting resources to lead the planning and implementation process. 35. Community teams such as the Heart Failure Specialist Nurse Service also work in conjunction with colleagues in the local authority facilitating the support of patients in the community using assisted technology such as Telecare and Telehealth. 36. A key focus from September 2012 will be the development of the commissioning intentions for Heart Disease and Stroke for RECOMMENDATIONS 37. The Governing Body is asked to note the scope of current work around heart disease and stroke services. 38. The Governing Body is also asked to support the details contained in the implementation plan and note the timescales involved. Dr Lesley Appleton, Clinical Lead for Heart Disease Paul Lynch, Planning & Performance Manager Vicky Oxford, Locality Support Manager September

10 Does this report / its recommendations have implications and impact with regard to the following: A. Clinical Commissioning Group Aims and Objectives 1. Quality (including patient safety, clinical effectiveness and patient experience) please outline impact The developments outlined in the report will significantly improve the quality of patient care and patient experience. 2. Commissioning Of Hospital And Community Services please outline impact The developments outlined in the report will impact on hospital and community services i.e. the commissioning of NTproBNP testing from secondary care pathology services, diagnostics in secondary care, delivery of specialist assessment in secondary care and the development of a cardiac rehabilitation programme for heart failure patients by community services. The Community Heart Failure Specialist Nurse Service will also be integrated within the heart failure pathway. The development of a cardiology one stop shop will have an impact on activity within secondary care. Yes Yes 3. Commissioning and Performance Management of GP Prescribing please outline impact Yes Earlier identification of heart failure and hypertension is likely to impact on prescribing as patients with these conditions will need to be clinically managed. However, it is anticipated that these costs will be off-set with savings generated by a reduction in hospital admissions. 4. Delivering Financial Balance please outline impact Yes The heart failure pathway is expected to deliver annual savings and the proposed cardiology one stop shop is anticipated to deliver savings through a reduction in out-patient activity. 5. Development Of The Clinical Commissioning Group as a Commissioning Organisation please outline impact No B. Governance please outline impact No 1. Does this report: provide the Governing Body with assurance against any of the risks identified in the assurance framework (identify risk number) have any legal implications promote effective governance practice 2. Additional resource implications (either financial or staffing resources) No 3. Health Inequalities No 4. Human Rights, Equality and Diversity Requirements No 9

11 5. Clinical Engagement Yes Has this report been developed with clinical input and do local clinicians support the report s recommendations? If yes, please outline the clinical engagement Heart Disease has been identified as a priority by practices and clinical Leads. 6. Patient and Public Engagement Yes Patients and Public Engagement around the Clinical Commissioning Group s Strategy identified heart disease and priority area. 10

Draft Falls Prevention Strategy

Draft Falls Prevention Strategy Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention

More information

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4 GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services

More information

BOARD REPORT AGENDA ITEM NO: WCCCGB/12/05/52 DATE OF BOARD MEETING: Health

BOARD REPORT AGENDA ITEM NO: WCCCGB/12/05/52 DATE OF BOARD MEETING: Health BOARD REPORT DATE OF BOARD MEETING: TITLE OF REPORT: KEY MESSAGES: Clinical Commissioning Priority Update: Alcohol Related Ill Health West Cheshire Clinical Commissioning Group has identified alcohol related

More information

2. Quality and Outcomes Framework: new NICE recommendations

2. Quality and Outcomes Framework: new NICE recommendations Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up

More information

Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire

Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning

More information

REPORT TO CLINICAL COMMISSIONING GROUP

REPORT TO CLINICAL COMMISSIONING GROUP REPORT TO CLINICAL COMMISSIONING GROUP 12th December 2012 Agenda No. 6.2 Title of Document: Report Author/s: Lead Director/ Clinical Lead: Contact details: Commissioning Model for Dementia Care Dr Aryan

More information

That the Single Commissioning Board supports the project outlined in this report and proceeds as described.

That the Single Commissioning Board supports the project outlined in this report and proceeds as described. Report to: SINGLE COMMISSIONING BOARD Date: 26 September 2017 Officer of Single Commissioning Board Subject: Report Summary: Recommendations: Jessica Williams Interim Director of Commissioning ATRIAL FIBRILLATION

More information

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:

More information

ELR CCG Annual General Meeting. Tuesday 26 September 2017

ELR CCG Annual General Meeting. Tuesday 26 September 2017 ELR CCG Annual General Meeting Tuesday 26 September 2017 1 Programme Welcome and introductions Responses to questions submitted today A patient and carer experience - Living with Dementia An introduction

More information

NHS Sheffield Community Pharmacy Catch Up Seasonal Flu Vaccination Programme for hard to reach at risk groups

NHS Sheffield Community Pharmacy Catch Up Seasonal Flu Vaccination Programme for hard to reach at risk groups NHS Sheffield Community Pharmacy Catch Up Seasonal Flu Vaccination Programme for hard to reach at risk groups 2011-12 Service Evaluation Supported by Sheffield Local Pharmaceutical Committee Supporting

More information

PRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016

PRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016 Part 1 Part 2 PRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016 Title of Report Supporting deaf patients to access primary care services Purpose of the Report The report is to provide the co-commissioning

More information

Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services?

Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Dr PARIJAT DE DUK Clinical Champion Clinical Lead for Diabetes & Endocrinology, Sandwell & West

More information

ROLE SPECIFICATION FOR MACMILLAN GPs

ROLE SPECIFICATION FOR MACMILLAN GPs ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN 2016-2021 1 1. Introduction Herts Valleys Palliative and End of Life Care Strategy is guided by the End of Life Care Strategic

More information

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan POLICY BRIEFING Prime Minister s challenge on dementia 2020 implementation plan Date: 14th March 2016 Author: Christine Heron LGiU associate Summary The Prime Minister s challenge on dementia contains

More information

Dianne Johnson / Lee Panter / Sarah McNulty

Dianne Johnson / Lee Panter / Sarah McNulty Cardiovascular Disease (heart disease and stroke) READER INFORMATION Need Identified Lead Author Cardiovascular Disease Dianne Johnson / Lee Panter / Sarah McNulty Date completed 07/02/11 Director approved

More information

Commissioning for Better Outcomes in COPD

Commissioning for Better Outcomes in COPD Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning

More information

DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND

DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS 2013-14 AND 2014-15 RECOMMENDATION/WORKPLAN CURRENT POSITION IN D & G PLAN 1. Annual Report 1.1 Develop robust reporting mechanisms

More information

Lincolnshire JSNA: Stroke

Lincolnshire JSNA: Stroke Lincolnshire JSNA: Stroke What do we know? Summary Around 2% of the population in Lincolnshire live with the consequences of this disease (14, 280 people) in 2010 Over 1,200 people were admitted for stroke

More information

The next steps

The next steps Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater

More information

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards

More information

Item No: 6. Meeting Date: Tuesday 12 th December Glasgow City Integration Joint Board Performance Scrutiny Committee

Item No: 6. Meeting Date: Tuesday 12 th December Glasgow City Integration Joint Board Performance Scrutiny Committee Item No: 6 Meeting Date: Tuesday 12 th December 2017 Glasgow City Integration Joint Board Performance Scrutiny Committee Report By: Susanne Millar, Chief Officer, Strategy & Operations / Chief Social Work

More information

PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME

PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME 1. BACKGROUND: 1.1 Primary Care 90% of mental health care is provided within primary care services, with the most common mental health problems identified

More information

NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups (and catch up campaign for over 65s)

NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups (and catch up campaign for over 65s) NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups 2012-13 (and catch up campaign for over 65s) Service Evaluation! Supported by Sheffield!Local!Pharmaceutical!Committee!

More information

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report Report by the Comptroller and Auditor General HC 82 SesSIon 2009 2010 14 January 2010 Improving Dementia Services in England an Interim Report 4 Summary Improving Dementia Services in England an Interim

More information

Coronary heart disease and stroke

Coronary heart disease and stroke 4 Coronary heart disease and stroke Overview of cardiovascular disease Cardiovascular disease (CVD), also called circulatory disease, describes a group of diseases which are caused by blockage or rupture

More information

MCIP Recruitment Pack

MCIP Recruitment Pack MCIP Recruitment Pack Page 1 of 13 Welcome Thank you for the interest you have shown in the MCIP Programme. An exciting partnership has been established to redesign cancer care in Manchester. Funded by

More information

Commissioning for value focus pack

Commissioning for value focus pack Commissioning for value focus pack Clinical commissioning group: NHS MILTON KEYNES CCG Focus area: Cardiovascular disease (CVD) pathway Version 2 June 2014 Contents 1. Background and context About the

More information

NHS Diabetes Programme

NHS Diabetes Programme NHS Diabetes Programme London Regional Event Vision Through the NHS Diabetes Programme we will aim to slow the future growth in the incidence of diabetes and reduce the rate of complications associated

More information

National Diabetes Treatment and Care Programme

National Diabetes Treatment and Care Programme National Diabetes Treatment and Care Programme Introduction to and supporting documentation for VALUE BASED TRANSFORMATION FUNDING SITE SELECTION December 2016 1 Introduction and Contents The Planning

More information

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...

More information

SCHEDULE 2 THE SERVICES. A. Service Specifications

SCHEDULE 2 THE SERVICES. A. Service Specifications SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification 11J/0232 No. Service Enhanced Frailty Service (Christchurch MP and Farmhouse Surgery) Commissioner Lead Primary Care Team Provider

More information

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG Shaping Diabetes Services in Southern Derbyshire A vision for Diabetes Services For Southern Derbyshire CCG Vanessa Vale Commissioning Manager September 2013 Contents 1. Introduction 3 2. National Guidance

More information

Northamptonshire Hospice Charities Strategy

Northamptonshire Hospice Charities Strategy Northamptonshire Hospice Charities Strategy Please note that sections in italics are comments related to the main statement above it. Introduction This document sets out how the hospice charities in Northamptonshire

More information

SCHEDULE 2 THE SERVICES. A. Service Specifications

SCHEDULE 2 THE SERVICES. A. Service Specifications SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 04/MSKT/0013 Service PAN DORSET FRACTURE LIAISON SERVICE Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead Deputy

More information

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes

More information

Dementia Strategy MICB4336

Dementia Strategy MICB4336 Dementia Strategy 2013-2018 MICB4336 Executive summary The purpose of this document is to set out South Tees Hospitals Foundation Trust s five year strategy for improving care and experience for people

More information

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY What is your view of the effects of the demographic change and an ageing population on the

More information

Networking for success: A burning platform in Berkshire West

Networking for success: A burning platform in Berkshire West SERVICE REDESIGN CASE STUDY 1: NOVEMBER 2014 Networking for success: A burning platform in Berkshire West SUMMARY In 2012, four federated CCGs set up a network to redesign diabetes services in Berkshire

More information

CCG Governing Board Meeting

CCG Governing Board Meeting CCG Governing Board Meeting Date of Meeting: 20 th July 2012 Agenda Item: Subject: Reporting Officer: Paper 19 (viii) Seasonal influenza immunisation programme report September 2011- March 2012 Christine

More information

Primary Health Networks

Primary Health Networks Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Drug and Alcohol Treatment Budget Murray PHN When submitting this Activity Work Plan 2016-2018 to the Department

More information

NHS Rotherham Clinical Commissioning Group

NHS Rotherham Clinical Commissioning Group NHS Rotherham Clinical Commissioning Group Operational Executive: 2 nd November 2015 Governing Body: 4 th November 2015 Review of Stroke Care Pathway GP Lead: Dr Phil Birks Lead Executive: Keely Firth

More information

HC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme

HC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme Report by the Comptroller and Auditor General HC 963 SesSIon 2008 2009 12 november 2009 Department of Health Young people s sexual health: the National Chlamydia Screening Programme 4 Summary Young people

More information

Communications and Engagement Approach

Communications and Engagement Approach Communications and Engagement Approach 2016-2020 NHS Cumbria CCG commissioning hospital and community services to get the best healthcare and health outcomes for our communities Contents Section 1 Section

More information

NHS England (West Yorkshire) Dental Commissioning Update 2015/16

NHS England (West Yorkshire) Dental Commissioning Update 2015/16 Report of NHS England North (Yorkshire and Humber) to the meeting of the Health and Social Care Overview & Scrutiny Committee to be held on 08 October 2015 Subject: NHS England (West Yorkshire) Dental

More information

Case Study. A Campaign to Raise Awareness of Atrial Fibrillation (AF) in Lancashire. June 2015.

Case Study. A Campaign to Raise Awareness of Atrial Fibrillation (AF) in Lancashire. June 2015. Case Study A Campaign to Raise Awareness of Atrial Fibrillation (AF) in Lancashire. June 2015. North West Coast Academic Health Science Network AF/Stroke Prevention Programme Academic Health Science Networks

More information

Appendix A: SECTION THREE: Engagement & participation Activity 2014/15. Objective Area of work What we did, who we engaged and how we did it?

Appendix A: SECTION THREE: Engagement & participation Activity 2014/15. Objective Area of work What we did, who we engaged and how we did it? Procurement of a physical activity programme CANCER Macmillan Physical Activity Programme Patient involvement in procurement of Macmillan Physical Activity Programme. This was initially an Invitation to

More information

People living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals

People living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals PROJECT INITIATION DOCUMENT We re in it together People living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals Version: 1.1 Date: February 2011 Authors: Jillian

More information

South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member

South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:

More information

Bedfordshire, Luton and Milton Keynes (BLMK) Sustainability and Transformation Partnership (STP) Central Brief: October 2017

Bedfordshire, Luton and Milton Keynes (BLMK) Sustainability and Transformation Partnership (STP) Central Brief: October 2017 Bedfordshire, Luton and Milton Keynes (BLMK) Sustainability and Transformation Partnership (STP) Central Brief: October 2017 Issue date: 2 November 2017 News Work progresses on proposed merger of Bedfordshire

More information

Sandwell Safeguarding Adults Board. ANNUAL REPORT 2016/2017 Executive Summary

Sandwell Safeguarding Adults Board. ANNUAL REPORT 2016/2017 Executive Summary Sandwell Safeguarding Adults Board SSAB@SSAdultsBoard ANNUAL REPORT 2016/2017 Executive Summary SEE SOMETHING DO SOMETHING Safeguarding is everyone s business SEE SOMETHING If you are concerned that an

More information

Healthy London Partnership - Prevention Programme Healthy Steps Together Expression of interest

Healthy London Partnership - Prevention Programme Healthy Steps Together Expression of interest Healthy London Partnership - Prevention Programme Healthy Steps Together Expression of interest October 2015 Register your interest to become a stage 1 Partner Demonstrator Site in a school, social housing

More information

Draft v1.3. Dementia Manifesto. London Borough of Barnet & Barnet Clinical. Autumn 2015

Draft v1.3. Dementia Manifesto. London Borough of Barnet & Barnet Clinical. Autumn 2015 Dementia Manifesto for Barnet Draft v1.3 London Borough of Barnet & Barnet Clinical Commissioning Group 1 Autumn 2015 .it is estimated that by 2021 the number of people with dementia in Barnet will grow

More information

Community alcohol detoxification in primary care

Community alcohol detoxification in primary care Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their

More information

Diabetes Public Meeting: Improving Diabetes Care in Hounslow

Diabetes Public Meeting: Improving Diabetes Care in Hounslow Diabetes Public Meeting: Improving Diabetes Care in Hounslow Report from the Public Meeting held on: Wednesday 18th March 2015 at Days Inn Hotel, 8 10, Lampton Rd, Hounslow Hounslow CCG Diabetes Public

More information

Section 1: Contact details Name of practice or organisation (e.g. charity) NHS Milton Keynes Clinical Commissioning Group and partners

Section 1: Contact details Name of practice or organisation (e.g. charity) NHS Milton Keynes Clinical Commissioning Group and partners Section 1: Contact details Name of practice or organisation (e.g. charity) NHS Milton Keynes Clinical Commissioning Group and partners Title of person writing the case study Neighbourhood Pharmacist &

More information

Dorset Health Scrutiny Committee

Dorset Health Scrutiny Committee Dorset Health Scrutiny Committee Date of Meeting 15 June 2018 Officer/Author Diane Bardwell, Dementia Services Review Project Manager, NHS Dorset Clinical Commissioning Group Subject of Report Dementia

More information

GP Cluster Network Action Plan Upper Valleys Cluster

GP Cluster Network Action Plan Upper Valleys Cluster GP Cluster Network Action Plan 2015-16 Upper Valleys Cluster The Cluster Network 1 Development Domain supports GP Practices to work to collaborate to: Understand local health needs and priorities. Develop

More information

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed

More information

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change?

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change? SCOTTISH GOVERNMENT: NEXT MENTAL HEALTH STRATEGY Background The current Mental Health Strategy covers the period 2012 to 2015. We are working on the development of the next strategy for Mental Health.

More information

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:

More information

Leeds Cancer Strategy

Leeds Cancer Strategy Leeds Cancer Strategy Public launch event Joanna Bayton-Smith, Macmillan Leeds Cancer Programme Manager Joanna.bayton-smith@nhs.net/ 0113 8435634 Professor Sean Duffy, Strategic Clinical Cancer Lead, Leeds

More information

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY

More information

NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY

NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY Agenda Item No: Part 1 X Part 2 NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 25.4.17 Title of Report Purpose of the Report Public Health Update This report provides an update to the Clinical

More information

Palliative & End of Life Care Plan

Palliative & End of Life Care Plan Palliative & End of Life Care Plan 2018-2023 Contents 1. Palliative Care Definition Page 1 2. Our Vision Page 2 3. Key Aims Page 2 4. Planned Actions Page 3-5 5. Priorities Page 6-7 6. Appendix 1 HSCP

More information

Adult Obesity. (also see Childhood Obesity) Headlines. Why is this important? Story for Leeds

Adult Obesity. (also see Childhood Obesity) Headlines. Why is this important? Story for Leeds Adult Obesity (also see Childhood Obesity) Headlines raise awareness of the scale, complexity and evidence base in relation to this issue, including promotion of the Change4Life campaign contribute to

More information

Sexual Health Services (Emergency Hormonal Contraception, Chlamydia Screening, Condom Distribution & Pregnancy Testing) in Pharmacies.

Sexual Health Services (Emergency Hormonal Contraception, Chlamydia Screening, Condom Distribution & Pregnancy Testing) in Pharmacies. Local Enhanced Service (LES) Specification for: Sexual Health Services (Emergency Hormonal Contraception, Chlamydia Screening, Condom Distribution & Pregnancy Testing) in Pharmacies. 1. Introduction 2.

More information

Barnet Scrutiny Committee report 13 th October Barnet Sexual Health Strategy Dr Andrew Howe, Director of Public Health

Barnet Scrutiny Committee report 13 th October Barnet Sexual Health Strategy Dr Andrew Howe, Director of Public Health Barnet Scrutiny Committee report 13 th October 2015 Title Report of Wards Status Urgent Key Enclosures Officer Contact Details Barnet Sexual Health Strategy 2015-2020 Dr Andrew Howe, Director of Public

More information

Our Summary Annual Report and Quality Account for 2015/16. gmw.nhs.uk

Our Summary Annual Report and Quality Account for 2015/16. gmw.nhs.uk Our Summary Annual Report and Quality Account for 2015/16 gmw.nhs.uk Reporting back, Looking Forward 3 Reporting Back 2015/16 has continued to see significant challenge facing the NHS nationally, and

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES 04e SCHEDULE 2 THE SERVICES A. Service Specifications This is a non-mandatory model template for local population. Commissioners may retain the structure below, or may determine their own in accordance

More information

Cancer Transformation Programme

Cancer Transformation Programme Cancer Transformation Programme Introduction to and supporting documentation for VALUE BASED TRANSFORMATION FUNDING SITE SELECTION November 2016 1 Introduction and Contents The Planning Guidance for 2017-2019

More information

DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN

DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN 2016-2019 1 Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-2019 Primary Health Tasmania t: 1300 653 169 e: info@primaryhealthtas.com.au

More information

Tackling atrial fibrillation the health economics evidence

Tackling atrial fibrillation the health economics evidence Tackling atrial fibrillation the health economics evidence Professor Gary Ford,CBE Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals

More information

Annual General Meeting

Annual General Meeting NHS Harrogate and Rural District CCG Annual General Meeting. 2 August 2018 1 Welcome and introductions Dr Alistair Ingram Clinical Chair NHS Harrogate and Rural District Clinical Commissioning Group 2

More information

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two

More information

Cardiology The interface between Primary and Secondary Care

Cardiology The interface between Primary and Secondary Care Cardiology The interface between Primary and Secondary Care Dr A Daniels GP, Cardiff South East Wales Cardiac Network The view from secondary care Referral to treatment times targets Clinics are full of

More information

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...

More information

Compare your care. How asthma care in England matches up to standards R E S P I R AT O R Y S O C I E T Y U K

Compare your care. How asthma care in England matches up to standards R E S P I R AT O R Y S O C I E T Y U K Compare your care How asthma care in England matches up to standards PRIMARY CARE R E S P I R AT O R Y S O C I E T Y U K Asthma matters Around 4.5 million people in England that s 1 in 11 are being treated

More information

NICE support for commissioning for urinary tract infection in infants, children and young people under 16

NICE support for commissioning for urinary tract infection in infants, children and young people under 16 NICE support for commissioning for urinary tract infection in infants, children and young people under 16 July 2013 1 Introduction Implementing the recommendations from NICE guidance and other NICEaccredited

More information

Our dementia STRATEGY

Our dementia STRATEGY South Tyneside and Sunderland Healthcare Group Our dementia STRATEGY 2018-2021 City Hospitals Sunderland and South Tyneside NHS Foundation Trusts working in partnership Introduction Dementia has become

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES 1 SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination

More information

Reshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality

Reshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality Reshaping Care Pathways for Older People Anne Hendry National Clinical Lead for Quality Reshaping Care for Older People 10 Year Programme to 2021 300 million Change Fund to 2015 32 Partnerships between

More information

The NHS Cancer Plan: A Progress Report

The NHS Cancer Plan: A Progress Report DEPARTMENT OF HEALTH The NHS Cancer Plan: A Progress Report LONDON: The Stationery Office 9.25 Ordered by the House of Commons to be printed on 7 March 2005 REPORT BY THE COMPTROLLER AND AUDITOR GENERAL

More information

Primary Health Networks

Primary Health Networks Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Hunter New England & Central Coast Please note: This Activity Work Plan was developed in response to the HNECC PHN

More information

Dementia Services; Past, Present and Future. Jo Dickinson Strategy and Planning Manager Southend Borough Council

Dementia Services; Past, Present and Future. Jo Dickinson Strategy and Planning Manager Southend Borough Council Dementia Services; Past, Present and Future. Jo Dickinson Strategy and Planning Manager Southend Borough Council Past, Present and Future. Introduction Background Information Current Services Future Services

More information

ALCOHOL AND DRUGS PLANNING FRAMEWORK

ALCOHOL AND DRUGS PLANNING FRAMEWORK ALCOHOL AND DRUGS PLANNING FRAMEWORK 1. NATIONAL CONTEXT 1.1 Scotland continues to have the highest alcohol and drug-related death rates in the UK with drug and alcohol problems particularly affecting

More information

The role of cancer networks in the new NHS

The role of cancer networks in the new NHS The role of cancer networks in the new NHS October 2012 UK Office, 89 Albert Embankment, London SE1 7UQ Questions about cancer? Call the Macmillan Support Line free on 0808 808 00 00 or visit macmillan.org.uk

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Nutrition support in adults: oral supplements, enteral and parenteral feeding. 1.1 Short title Nutrition support 2 Background a) The National

More information

Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING. Meeting Date: 7 November Report Author: Report Sponsor:

Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING. Meeting Date: 7 November Report Author: Report Sponsor: Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 7 November 2013 Report Sponsor: Dr Emma Broughton Clinical Lead for Primary Care Programme Report Author:

More information

ACTIVE TAMESIDE STRATEGY, GROWTH AND DEVELOPMENT

ACTIVE TAMESIDE STRATEGY, GROWTH AND DEVELOPMENT Report to: HEALTH AND WELLBEING BOARD Date: 19 January 2017 Board Member / Reporting Officer: Subject: Report Summary: Recommendations: Links to Health and Wellbeing Strategy: Policy Implications: Financial

More information

Dumfries and Galloway Alcohol and Drug Partnership. Strategy

Dumfries and Galloway Alcohol and Drug Partnership. Strategy Dumfries and Galloway Alcohol and Drug Partnership Strategy 2017 2020 1 Contents Foreword...3 1. Introduction... 4 1.1 Background... 4 1.2 Aim... 4 1.3 National Context... 4 2. Strategic Priorities...

More information

Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle

Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle Contents 1. Agreement period 2. Scope 3. Targets 4. Service outline 5. Support for clients using

More information

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Putting NICE guidance into practice Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Published: June 2014 This costing report accompanies the clinical

More information

Enhanced CPD Programme Module 1. Introducing Starting Well

Enhanced CPD Programme Module 1. Introducing Starting Well Enhanced CPD Programme Module 1 Introducing Starting Well Contents Where did the need of the scheme come from? In summary, what is the scheme about? How will the scheme work? Preventive Practices Advanced

More information

CHOOSING WISELY FOR KINGSTON PROPOSED CHANGES TO LOCAL HEALTHCARE - IVF

CHOOSING WISELY FOR KINGSTON PROPOSED CHANGES TO LOCAL HEALTHCARE - IVF GOVERNING BODY LEAD: Fergus Keegan, Director of Quality, Kingston & Richmond CCGs REPORT AUTHOR: Sue Lear, Acting Deputy Director of Commissioning ATTACHMENT: AGENDA ITEM: D2 RECOMMENDATION: The Governing

More information

West Cheshire Children s Trust Executive

West Cheshire Children s Trust Executive West Cheshire Children s Trust Executive Action Note of meeting held on Monday 13 th July 2015 (Palatine Room, Chester Town Hall) In attendance: Gerald Meehan Strategic Director, Children and Families

More information

Enhancing the Quality of Heart Failure Care

Enhancing the Quality of Heart Failure Care Enhancing the Quality of Heart Failure Care 2 Enhancing the quality of Heart Failure care Contents 2 Heart failure care in the UK: Case for change Heart failure in the UK: Case for change Heart failure

More information

HIGH BLOOD PRESSURE. How can we do better?

HIGH BLOOD PRESSURE. How can we do better? HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high

More information

Planning for delivery in 15/16 for the Dementia and IAPT Ambitions

Planning for delivery in 15/16 for the Dementia and IAPT Ambitions Planning for delivery in 15/16 for the Dementia and IAPT Ambitions 24th March 2015 Welcome to the planning WebEx: Dementia and IAPT delivery in 2015/16 Please ensure you are logged into the audio via a

More information